Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 2/2024

27-10-2023 | Vestibular Migraine | Episodic Migraine (S Parikh, Section Editor)

Vestibular Migraine Pathophysiology and Treatment: a Narrative Review

Author: Claire E. J. Ceriani

Published in: Current Pain and Headache Reports | Issue 2/2024

Login to get access

Abstract

Purpose of Review

To review the diagnosis of vestibular migraine (VM) and update the clinician on the most recent developments in our understanding of its pathophysiology and treatment.

Recent Findings

Functional imaging studies have identified multiple regions of the brain with abnormal activity and connectivity in VM. There is evidence of abnormal sensory processing and integration in VM patients. Calcitonin gene-related peptide (CGRP) has also been found to play a role in trigeminal and vestibular nucleus pathways. Research into treatment modalities has identified several neuromodulation devices that may be effective in VM. There are a growing number of evidence-based preventive options for VM, including medications that target CGRP.

Summary

VM is best understood as a sensory processing disorder. CGRP appears to play a role, and further research is needed to fully understand its effects. Treatment options are expanding, but there is still a need for more randomly controlled trials in this area.
Literature
1.
•• Mallampalli MP, Rizk HG, Kheradmand A, Beh SC, Abouzari M, Bassett AM et al. Care gaps and recommendations in vestibular migraine: an expert panel summit. Front Neurol. 2021;12:812678. A recent publication highlighting the care gaps in VM and need for further research.
2.
Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
3.
•• Teggi R, Colombo B, Albera R, Asprella Libonati G, Balzanelli C, Batuecas Caletrio A et al. Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: the VM-phenotypes projects. Headache. 2018;58(4):534–44. An important study for defining the clinical range of VM presentation.
4.
Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol. 2016;263(Suppl 1):S82–9.PubMedCrossRef
5.
• Iljazi A, Ashina H, Lipton RB, Chaudhry B, Al-Khazali HM, Naples JG et al. Dizziness and vertigo during the prodromal phase and headache phase of migraine: a systematic review and meta-analysis. Cephalalgia. 2020;40(10):1095–103. A recent study of the prevalence of vestibular symptoms in migraine.
6.
Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol. 2018;39(8):1037–44.PubMedCrossRef
7.
Close LN, Eftekhari S, Wang M, Charles AC, Russo AF. Cortical spreading depression as a site of origin for migraine: Role of CGRP. Cephalalgia. 2019;39(3):428–34.PubMedCrossRef
8.
Aurora SK, Wilkinson F. The brain is hyperexcitable in migraine. Cephalalgia. 2007;27(12):1442–53.PubMedCrossRef
9.
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;553–622.
10.
11.
12.
13.
Winnick A, Sadeghpour S, Otero-Millan J, Chang TP, Kheradmand A. Errors of upright perception in patients with vestibular migraine. Front Neurol. 2018;9:892.PubMedPubMedCentralCrossRef
14.
Bednarczuk NF, Bonsu A, Ortega MC, Fluri AS, Chan J, Rust H, et al. Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study. Brain. 2019;142(3):606–16.PubMedPubMedCentralCrossRef
15.
• Zhang Y, Zhang Y, Wang Y, Zhang X, Qin G, Zhang D et al. Inhibition of glutamatergic trigeminal nucleus caudalis- vestibular nucleus projection neurons attenuates vestibular dysfunction in the chronic-NTG model of migraine. J Headache Pain. 2023;24(1):77. Recent findings suggesting a potential therapeutic target in VM.
16.
• Zhang Y, Zhang Y, Tian K, Wang Y, Fan X, Pan Q et al. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine. J Headache Pain. 2020;21(1):72. Recent findings linking CGRP to VM.
17.
Toriyama T, Hanaoka Y, Horiuchi T. Clinical features of definite vestibular migraine through the lens of central sensitization: a cross-sectional study. Acta Neurol Belg. 2022;122(6):1511–9.PubMedCrossRef
18.
Zhe X, Tang M, Ai K, Lei X, Zhang X, Jin C. Decreased ALFF and functional connectivity of the thalamus in vestibular migraine patients. Brain Sci. 2023;13(2).
19.
Chen Z, Xiao L, Liu H, Zhang Q, Wang Q, Lv Y, et al. Altered thalamo-cortical functional connectivity in patients with vestibular migraine: a resting-state fMRI study. Neuroradiology. 2022;64(1):119–27.PubMedCrossRef
20.
Zhang B, Wu D, Guo Y, Yan W, Liu X, Yang Z, et al. Altered large-scale internetwork functional connectivity in patients with vestibular migraine and migraine without aura. Neurosci Lett. 2023;800: 137123.PubMedCrossRef
21.
Han L, Lu J, Chen C, Ke J, Zhao H. Altered functional connectivity within and between resting-state networks in patients with vestibular migraine. Neuroradiology. 2023;65(3):591–8.PubMedCrossRef
22.
Wang S, Wang H, Liu X, Yan W, Wang M, Zhao R. A resting-state functional MRI study in patients with vestibular migraine during interictal period. Acta Neurol Belg. 2023;123(1):99–105.PubMedCrossRef
23.
Chen Z, Rong L, Xiao L, Wang Q, Liu Y, Lin C, et al. Altered brain function in patients with vestibular migraine: a study on resting state functional connectivity. Neuroradiology. 2023;65(3):579–90.PubMedCrossRef
24.
Chen Z, Liu H, Wei XE, Wang Q, Liu Y, Hao L, et al. Aberrant dynamic functional network connectivity in vestibular migraine patients without peripheral vestibular lesion. Eur Arch Otorhinolaryngol. 2023;280(6):2993–3003.PubMedCrossRef
25.
Zhe X, Chen L, Zhang D, Tang M, Gao J, Ai K, et al. Cortical areas associated with multisensory integration showing altered morphology and functional connectivity in relation to reduced life quality in vestibular migraine. Front Hum Neurosci. 2021;15: 717130.PubMedPubMedCentralCrossRef
26.
Li ZY, Si LH, Shen B, Yang X. Altered brain network functional connectivity patterns in patients with vestibular migraine diagnosed according to the diagnostic criteria of the Barany Society and the International Headache Society. J Neurol. 2022;269(6):3026–36.PubMedCrossRef
27.
• Li ZY, Si LH, Shen B, Ling X, Yang X. Altered functional activity in the right superior temporal gyrus in patients with definite vestibular migraine. Neurol Sci. 2023;44(5):1719–29. Recent study finding fMRI differences between VM and non-vestibular migraine patients.
28.
Zhe X, Zhang X, Chen L, Zhang L, Tang M, Zhang D, et al. Altered gray matter volume and functional connectivity in patients with vestibular migraine. Front Neurosci. 2021;15: 683802.PubMedPubMedCentralCrossRef
29.
Zhe X, Gao J, Chen L, Zhang D, Tang M, Yan X, et al. Altered structure of the vestibular cortex in patients with vestibular migraine. Brain Behav. 2020;10(4): e01572.PubMedPubMedCentralCrossRef
30.
Versino M, Mandala M, Colnaghi S, Ricci G, Faralli M, Ramat S. The integration of multisensory motion stimuli is impaired in vestibular migraine patients. J Neurol. 2020;267(10):2842–50.PubMedCrossRef
31.
Tang B, Yu X, Jiang W, Zhang C, Zhan T, He Y. Clinical significance of serum sex hormones in postmenopausal women with vestibular migraine: potential role of estradiol. J Int Med Res. 2021;49(5):3000605211016379.PubMedCrossRef
32.
Mucci V, Hamid M, Jacquemyn Y, Browne CJ. Influence of sex hormones on vestibular disorders. Curr Opin Neurol. 2022;35(1):135–41.PubMedCrossRef
33.
von Brevern M, Ta N, Shankar A, Wiste A, Siegel A, Radtke A, et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache. 2006;46(7):1136–41.CrossRef
34.
Sumalde AAM, Scholes MA, Kalmanson OA, Terhune EA, Frejo L, Wethey CI et al. Rare coding variants in patients with non-syndromic vestibular dysfunction. Genes. 2023;14(4).
35.
Familiari M, Gatti O, Cangiano I, Teggi R. A family with a high incidence of migraine and vestibular migraine and a case of Meniere’s disease. Case Rep Med. 2021;2021:9984047.PubMedPubMedCentralCrossRef
36.
37.
Paz-Tamayo A, Perez-Carpena P, Lopez-Escamez JA. Systematic review of prevalence studies and familial aggregation in vestibular migraine. Front Genet. 2020;11:954.PubMedPubMedCentralCrossRef
38.
Roberts RA, Watford KE, Picou EM, Hatton K, Trone TH, Brignola EY. Effects of lifestyle modification on vestibular migraine. Otol Neurotol. 2021;42(10):e1537–43.PubMedCrossRef
39.
Sun L, Li G, Liu F, Wang Y, Zhang L, Minoret C. Resistance exercise relieves symptoms of vestibular migraine patients with MRI diagnosis: a randomized parallel-controlled single-blind clinical trial. Rev Neurol. 2022;178(4):370–6.PubMedCrossRef
40.
Balci B, Akdal G. Outcome of vestibular rehabilitation in vestibular migraine. J Neurol. 2022;269(12):6246–53.PubMedCrossRef
41.
Koc A, Cevizci Akkilic E. Effects of vestibular rehabilitation in the management of patients with and without vestibular migraine. Braz J Otorhinolaryngol. 2022;88(Suppl 3):S25-S33.
42.
Stancel-Lewis J, Lau JWL, Male A, Korres G, Rogel-Salazar J, Pavlou M, et al. Vestibular rehabilitation therapy for the treatment of vestibular migraine, and the impact of traumatic brain injury on outcome: a retrospective study. Otol Neurotol. 2022;43(3):359–67.PubMedCrossRef
43.
44.
Vitkovic J, Winoto A, Rance G, Dowell R, Paine M. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.PubMedCrossRef
45.
• Beh SC. External trigeminal nerve stimulation: potential rescue treatment for acute vestibular migraine. J Neurol Sci. 2020;408:116550. A study of neuromodulation as a treatment in VM and discussion of possible underlying pathophysiology.
46.
Beh SC, Friedman DI. Acute vestibular migraine treatment with noninvasive vagus nerve stimulation. Neurology. 2019;93(18):e1715–9.PubMedCrossRef
47.
Beh SC. Nystagmus and vertigo in acute vestibular migraine attacks: response to non-invasive vagus nerve stimulation. Otol Neurotol. 2021;42(2):e233–6.PubMedCrossRef
48.
Magis D, D’Ostilio K, Thibaut A, De Pasqua V, Gerard P, Hustinx R, et al. Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia. 2017;37(9):881–91.PubMedCrossRef
49.
Lopez C, Blanke O. The thalamocortical vestibular system in animals and humans. Brain Res Rev. 2011;67(1–2):119–46.PubMedCrossRef
50.
51.
52.
Babic T, Browning KN. The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol. 2014;722:38–47.PubMedCrossRef
53.
Frangos E, Komisaruk BR. Access to vagal projections via cutaneous electrical stimulation of the neck: fMRI evidence in healthy humans. Brain Stimul. 2017;10(1):19–27.PubMedCrossRef
54.
Vanstrum EB, Doherty JK, Sinha UK, Voelker CCJ, Bassett AM. An exploration of online support community participation among patients with vestibular disorders. Laryngoscope. 2022;132(9):1835–42.PubMedCrossRef
55.
Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18:350–4.PubMed
56.
Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60:882–3.
57.
Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain. 2011;12(1):81–8.PubMedCrossRef
58.
Cassano D, Pizza V, Busillo V. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain. 2015;16(Suppl 1):A114.PubMedPubMedCentralCrossRef
59.
Hoskin JL, Fife TD. New anti-CGRP medications in the treatment of vestibular migraine. Front Neurol. 2021;12: 799002.PubMedCrossRef
60.
Baier B, Winkenwerder E, Dieterich M. "Vestibular migraine": effects of prophylactic therapy with various drugs. a retrospective study. J Neurol. 2009;256(3):436–42.
61.
Salmito MC, Duarte JA, Morganti LOG, Brandão PVC, Nakao BH, Villa TR, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol. 2017;83(4):404–10.PubMedCrossRef
62.
Lee SH, Jeong SH, Kim JS, Kim HJ, Choi KD, Choi JH, et al. Effect of prophylactic medication on associated dizziness and motion sickness in migraine. Otol Neurotol. 2017;39(1):e45–51.CrossRef
63.
Celik O, Tanyeri Toker G, Eskiizmir G, Incesulu A, Sahin SN. The effectiveness of medical prophylactic treatment on vestibular migraine and its effect on the quality of life. J Int Adv Otol. 2020;16(1):28–33.PubMedCrossRef
64.
Van Ombergen A, Van Rompaey V, Van de Heyning P, Wuyts F. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2014;36:133–8.CrossRef
65.
Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–6.PubMedCrossRef
66.
Taghdiri F, Togha M, Razeghi Jahromi S, Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus. 2014;3:231.PubMedPubMedCentralCrossRef
67.
Kaya I, Eraslan S, Tarhan C, Bilgen C, Kirazli T, Gokcay F, et al. Can verapamil be effective in controlling vertigo and headache attacks in vestibular migraine accompanied with Meniere’s disease? A preliminary study J Neurol. 2019;266(Suppl 1):62–4.PubMed
68.
Maita H, Kobayashi T, Akimoto T, Osawa H, Kato H. Vestibular migraine without headache treated with lomerizine: a 35-year-old woman undiagnosed for 10 years. J Gen Fam Med. 2020;21(4):140–2.PubMedPubMedCentralCrossRef
69.
• Bayer O, Adrion C, Al Tawil A, Mansmann U, Strupp M, investigators P. Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG). Trials. 2019;20(1):813. Though terminated early, the discussion of this randomized controlled trial provides insight into how future VM treatment trials should be designed.
70.
Gode S, Celebisoy N, Kirazli T, Akyuz A, Bilgen C, Karapolat H, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84.PubMedCrossRef
71.
Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol. 2012;33(1):121–7.PubMedCrossRef
72.
Celiker A, Bir LS, Ardic N. Effects of valproate on vestibular symptoms and electronystagmographic findings in migraine patients. Clin Neuropharmacol. 2007;30(4):213–7.PubMedCrossRef
73.
Bisdorff AR. Treatment of migraine related vertigo with lamotrigine: an observational study. Bull Soc Sci Med. 2004;2:103–8.MathSciNet
74.
Celebisoy N, Gokcay F, Karahan C, Bilgen C, Kirazli T, Karapolat H, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273(10):2947–51.PubMedCrossRef
75.
•• Russo CV, Sacca F, Braca S, Sansone M, Miele A, Stornaiuolo A et al. Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: a prospective observational cohort study. Cephalalgia. 2023;43(4):3331024231161809. A one-year study of 50 VM patients on CGRP monoclonal antibody treatment.
76.
• Oh SY, Kang JJ, Kim S, Lee JM, Kim JS, Dieterich M. A preliminary trial of botulinum toxin type A in patients with vestibular migraine: a longitudinal fMRI study. Front Neurol. 2022;13:955158. A study of botulinum toxin type A treatment with fMRI imaging before and after.
77.
Dominguez-Duran E, Montilla-Ibanez MA, Alvarez-Morujo de Sande MG, Domenech-Vadillo E, Becares-Martinez C, Gonzalez-Aguado R et al. Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug. Eur Arch Otorhinolaryngol. 2020;277(4):1013–21.
78.
Liu F, Ma T, Che X, Wang Q, Yu S. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol. 2017;8:524.PubMedPubMedCentralCrossRef
79.
Rashid SMU, Sumaria S, Koohi N, Arshad Q, Kaski D. Patient experience of flunarizine for vestibular migraine: single centre observational study. Brain Sci. 2022;12(4).
80.
•• Byun YJ, Levy DA, Nguyen SA, Brennan E, Rizk HG. Treatment of vestibular migraine: a systematic review and meta-analysis. Laryngoscope. 2021;131(1):186–94. A recent meta-analysis of 13 treatment studies.
81.
Gorur K, Gur H, Ismi O, Ozcan C, Vayisoglu Y. The effectiveness of propranolol, flunarizine, amitriptyline and botulinum toxin in vestibular migraine complaints and prophylaxis: a non-randomized controlled study. Braz J Otorhinolaryngol. 2022;88(6):975–81.PubMedCrossRef
82.
Liu YF, Macias D, Donaldson L, Dornhoffer JR, Rizk HG. Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine. J Laryngol Otol. 2020;134(7):586–91.PubMedCrossRef
83.
Ak AK, Celebisoy N, Ozdemir HN, Gokcay F, Saruhan Durmaz G, Top Karti D, et al. Factors determining the response to treatment in patients with vestibular migraine. Neurol Res. 2022;44(9):847–54.CrossRef
84.
Dornhoffer JR, Liu YF, Donaldson L, Rizk HG. Factors implicated in response to treatment/prognosis of vestibular migraine. Eur Arch Otorhinolaryngol. 2021;278(1):57–66.PubMedCrossRef
85.
Du Z, Li P, Bing D. Presence of diabetes mellitus affects vertigo outcome in vestibular migraine. Am J Otolaryngol. 2022;43(5): 103562.PubMedCrossRef
Metadata
Title
Vestibular Migraine Pathophysiology and Treatment: a Narrative Review
Author
Claire E. J. Ceriani
Publication date
27-10-2023
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 2/2024
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-023-01182-7